Den Bakker M A, van Tilborg A A, Kros J M, Zwarthoff E C
Department of Pathology, Erasmus University Rotterdam/Josephine Nefkens Institute, The Netherlands.
Neuropathology. 2001 Sep;21(3):168-73. doi: 10.1046/j.1440-1789.2001.00394.x.
Neurofibromatosis type 2 is caused by mutations in the NF2 tumor suppressor gene. The NF2 gene encodes a 595-aminoacid protein, presumably functioning as a membrane-organizing element. Theoretically, the majority of mutations found in the NF2 gene should lead to a truncated protein product. Using immunoprecipitation with an antibody raised to N-terminal sequences of the NF2 protein, the authors sought to demonstrate the presence of truncated NF2 proteins in tumors. From 17 of 19 tumors (14 meningiomas and five schwannomas), 12 of which have previously been shown to harbor truncating NF2 mutations, wild-type NF2 protein was immunoprecipitated. From two tumors no protein was precipitated. Truncated NF2 proteins were not observed. The authors conclude that mutant NF2 proteins are unstable and undergo accelerated degradation.
2型神经纤维瘤病由NF2肿瘤抑制基因突变引起。NF2基因编码一种含595个氨基酸的蛋白质,可能作为一种膜组织元件发挥作用。理论上,在NF2基因中发现的大多数突变应导致截短的蛋白质产物。作者利用针对NF2蛋白N端序列产生的抗体进行免疫沉淀,试图证明肿瘤中存在截短的NF2蛋白。在19个肿瘤(14个脑膜瘤和5个神经鞘瘤)中的17个中,其中12个先前已显示含有截短的NF2突变,野生型NF2蛋白被免疫沉淀。有两个肿瘤未沉淀出蛋白质。未观察到截短的NF2蛋白。作者得出结论,突变的NF2蛋白不稳定并经历加速降解。